Experts Advocate for Stricter FDA Oversight of Drug Promotions on Social Media

Experts from Mass General Brigham, in a commentary published in The New England Journal of Medicine, are urging the FDA to enhance its regulation of prescription drug promotion, particularly concerning celebrity endorsements and influencer campaigns on social media. They highlight that these promotions, especially for GLP-1s, often fail to adequately disclose risks and can mislead patients. The experts emphasize the need for updated regulations and expanded oversight to address these gaps.